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ABSTRACT 
Lasso peptides constitute a class of bioactive peptides sharing a knotted structure where the C-
terminal tail of the peptide is threaded through and trapped within an N-terminal macrolactam ring. The 
structural characterization of lasso structures and differentiation from their unthreaded topoisomers is 
not trivial and generally requires the use of complementary biochemical and spectroscopic methods. 
Here we investigated two antimicrobial peptides belonging to the class II lasso peptide family and their 
corresponding unthreaded topoisomers: microcin J25, which displays a typical lasso CID fragmentation 
pattern and capistruin, for which CID fragmentation does not permit to unambiguously assign the lasso 
structure. The two pairs of topoisomers were analyzed by ESI-FT-ICR-MS upon CID, IRMPD and 
ECD. Both CID and ECD spectra clearly permitted to differentiate MccJ25 from its non-lasso 
topoisomer, while for capistruin, only ECD was informative and showed different extent of hydrogen 
abstraction for the threaded and unthreaded topoisomers. This work shows the potentiality of ECD for 
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structural characterization of peptide topoisomers, as well as the effect of conformation on hydrogen 
abstraction subsequent to ECD. 
 
INTRODUCTION 
Molecular knots constitute original structural motifs in biomolecules and fascinating topological 
objects.
1-2
 Bioactive peptides with knotted structures, such as lasso peptides and cyclotides, share a knot 
topologically defined by covalent crosslinks (lactam ring and/or cysteine bridges) and display very 
compact and stable structures. Such structures therefore constitute valuable scaffolds with potential 
applications in peptide-based drug design.
3-4
 Lasso peptides form a class of bacteria-produced bioactive 
peptides with a threaded structure involving an 8/9-residue ring resulting from an amide bond between 
the N-terminus and the carboxylic group of an Asp/Glu residue, crossed by the C-terminal tail.
5
 They 
form three classes depending on the absence (class II) or presence of one (class III) or two (class I) 
disulfide bridges that further stabilize the structure.
6
 They exhibit a variety of biological activities, 
involving enzyme inhibition, receptor antagonism, antimicrobial or anti-HIV activities (see Table 1 for 
class II lasso peptides).
5,7-12
 Their compact structure confers to lasso peptides a great resistance to 
denaturing conditions and certain proteases. The structural characterization of lasso structures and 
differentiation from their unthreaded topoisomers is not trivial and generally requires the use of 
complementary biochemical and spectroscopic methods. 
Microcin J25 (MccJ25) is a lasso peptide secreted by Escherichia coli AY25 that exerts potent 
antibacterial activity against Escherichia and Salmonella species, through import in the target bacteria 
upon interaction with the iron-siderophore receptor FhuA
13
 and inhibition of the RNA polymerase.
14
 Its 
C-terminal (18-21 SFYG) segment is sterically entrapped into the macrolactam ring by F19 and Y20 
located on each side of the ring. Cleavage within the Y9-I18 region, either in solution by enzymatic 
cleavage or acidic hydrolysis, or in the gas-phase upon collision-induced dissociation (CID), generates 
two peptide complexes associated through the steric hindrance provided by the side chains of F19 and 
Y20.
15-17
 A particular gas-phase fragmentation pattern upon CID, as compared to the corresponding 
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synthetic peptide encompassing a macrolactam ring, has also been reported for the lasso peptide RES 
701-1,
18
 but generally only NMR could unambiguously characterize the threading of the C-terminal tail 
into the macrolactam rings.
7-8,19
 Capistruin is a lasso peptide secreted by Burkholderia thailandensis 
E264 discovered by genome mining, which exhibits antibacterial activities against closely related 
Burkholderia and Pseudomonas species.
8
 It showed a low overall fragmentation pattern upon CID. 
However, no two-peptide complexes unequivocally proving a lasso structure were observed.
8
 
Comparison of the three-dimensional structures of MccJ25 and capistruin shows that MccJ25 displays a 
large loop involving a short antiparallel -sheet and a very short C-terminal segment below the ring, 
while capistruin displays a very tight loop and a much longer C-terminal segment below the ring (Figure 
1). In both peptides, the steric entrapping of the C-terminal tail in the macrolactam ring relies on the 
presence of a bulky  amino acid located below the ring: Y20 for MccJ25
20
 and R15 for capistruin.
21
 In 
addition, both peptides contain a bulky  amino acid located above the ring: F19 for MccJ25 and R11 for 
capistruin. However, in capistruin the two bulky amino acids, R11 and R15, are not adjacent. 
Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry has shown a great 
capability for the analysis of peptides and proteins, in particular for the characterization of post-
translational modifications. The main advantages of this method are the high resolution provided by the 
ICR cell together with the multiple excitation modes available on this instrument, such as (i) collision-
induced dissociation (CID) in the external collision cell or in the ICR cell through sustained off 
resonance irradiation (SORI) under CID conditions,
22
 (ii) infrared multiphoton dissociation (IRMPD)
23
 
and (iii) for positive ions, electron-capture dissociation (ECD).
24-25
 The latter has revealed particularly 
appealing for the structural characterization of peptides and proteins
26
, given the ability to cleave the 
peptide backbone while leaving intact labile side-chain modifications, or without disrupting the non-
covalent interactions involved in the three-dimensional structure of proteins.
27-28
 In order to develop an 
analytical method to unambiguously characterize topoisomeric peptides by mass spectrometry, the 
fragmentation patterns MccJ25, capistruin, and their corresponding non-lasso topoisomers MccJ25-lcm 
and capistruin-lcm, were analyzed by ESI-FT-ICR-MS upon CID, SORI-CID, IRMPD and ECD. 
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EXPERIMENTAL SECTION 
Peptides 
MccJ25 was produced from a culture of E. coli MC4100 harboring the plasmid pTUC202, cultivated for 
16 h in M63 medium supplemented with 1 mg/mL vitamin B1, 0,02% MgSO4, 0,02% glucose and 1 g/L 
casamino acids. MccJ25 was purified from the culture supernatant by solid phase extraction on a 
SepPak C18 35 cc cartridge and by semi-preparative RP-HPLC on a C18 μBondapak column (300 mm 
× 3.9 mm, 10 μm, Waters).  
Capistruin was produced from a culture of Burkholderia thailandensis E264 incubated for 24 h at 42 °C 
in M20 medium containing gentamycin (8 μg/mL), as described previously.8 The purification was 
carried out by solid phase extraction followed by preparative RP-HPLC.
8
 
The synthetic cyclic branched peptides, MccJ25-lcm and capistruin-lcm, were obtained from Genepep 
(Montpellier, France). 
FT-ICR mass spectrometry 
Mass spectrometry experiments were performed on a hybrid Qh-FT/ICR (Bruker Daltonics, Bremen, 
Germany) equipped with an off-axis Apollo II ESI source operated in positive ion mode. A syringe 
pump was used to infuse the peptide solution (10 µM in H2O/CH3CN + 0.1% (v/v) formic acid) with a 
gas-tight syringe at a flow rate of 120 µL/h. CID experiments were performed in the collision cell or 
upon SORI-CID in the ICR cell using argon as collision gas. For SORI-CID, the ions were activated 
using a -1000 Hz frequency offset for 250 ms with a 3.3 Vp-p excitation amplitude. A pumping delay of 
2 s was applied prior to ion analysis. When necessary, MS
3
 experiments were conducted using CID in 
the collision cell in conjunction with either SORI-CID or IRMPD. ECD experiments were performed 
with an indirectly heated hollow cathode set to 1.7 A. Electrons emitted during 0.1 s were injected into 
the ICR cell with a 1.2 V bias.  
Nomenclature of the product ions 
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To avoid any ambiguity, the nomenclature introduced by Roepstorff and Folman,
29
 further modified by 
Biemann and coworkers,
30
 was adopted to describe the product ions. For internal fragment ions, the 
general presentation form is (brys)(r+s−t), where r, s and t indicate the number of amino acids cleaved 
counting from the N-terminus, the number of amino acids cleaved from the C-terminus and the total 
number of amino acid residues in the peptide, respectively. The subscript (r+s−t) thus accounts for the 
number of residues in the internal fragment. As an example, the internal fragment GIGTPI of MccJ25 
has r = 17, s = 10 and t = 21 and is denoted (b17y10)6. The product ions resulting from fragmentation in 
the loop of the lasso structure and where the C-terminal tail is threaded into the macrolactam ring were 
denoted [(br)*(ys)], where r and s indicate the number of amino acids in the non-covalently bound N-
terminal and C-terminal peptide segments. As an example, the product ion [MccJ25-{GIGTPI}] is 
denoted [(b11)*(y4)]. For ECD fragmentations, similar notation using c/z codes were used. The charge 
states were omitted for singly-charged species and indicated for doubly- and triply-charged species. 
 
RESULTS AND DISCUSSION 
Fragmentation patterns of MccJ25 and capistruin and their non-lasso topoisomers generated by CID, 
SORI-CID and IRMPD  
The CID spectra of MccJ25, capistruin, and their corresponding synthetic non-lasso topoisomers, 
MccJ25-lcm and capistruin-lcm, which contain the macrolactam ring but without steric entrapping of 
the C-terminal tail inside, were obtained through CID in the external collision cell or SORI-CID in the 
ICR cell. The spectra provided similar information, therefore only SORI-CID spectra are presented, 
since these experiments permit to avoid m/z discrimination during the ion transfer between the collision 
cell and the ICR cell. 
The SORI-CID spectrum of the M+3H3+ species of MccJ25 (m/z 703.0) showed a complicated 
fragmentation pattern, involving two competitive dissociation processes (Figure 2A, supplementary 
Table S1). On the one hand, extensive fragmentations in the Y9-I17 loop were detected, yielding typical 
two-peptide product ions resulting from the steric entrapping of the (SFYG) C-terminal segment in the 
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macrolactam ring, as already reported.
15,17
 The main product ions consisted of (b16)*(y4)
3+,2+
 and 
(b15)*(y4)
3+,2+
, with consecutive H2O and CO neutral losses, together with (b11)*(y6)
2+
 and 
(b11)*(y4)
2+
. Several internal product ions, complementary to the two-peptide product ions, were also 
detected: (b15y10)4, (b17y10)6, (b19y8)6, (b16y9)4… On the second hand, complementary y/b series 
corresponding to fragmentations in the C-terminal tail were detected. They consisted of the b8, b9, b10, 
b11
1+, 2+
, b12, b13
1+, 2+
, b19
2+
, b20
3+
 series, together with the y2, y3, y4 and y6 series (supplementary Table 
S1). These series indicated a release of the (SFYG) C-terminal segment and therefore that fragmentation 
in the macrolactam ring occurred. Alternatively, such product ions could result from consecutive 
dissociation from b20
3+
. Indeed, the loss of the C-terminal G21 residue may release the C-terminal tail. 
Finally, consecutive H2O and CO losses from the precursor ion were observed (M+3H-H2O
3+
 being 
the base peak of the spectrum). The SORI-CID spectrum of the M+2H2+ species of MccJ25 displayed 
a weak dissociation profile, with M+2H-H2O
2+
 as base peak (data not shown). The M+3H3+ species 
of MccJ25-lcm showed a more specific fragmentation pattern under SORI-CID than that of its lasso 
topoisomer (Figure 2B, supplementary Table S2). As for MccJ25, the base peak was M+3H-H2O
3+
 at 
m/z 697.0. The spectrum was dominated by the b series (singly-charged b9 to b13, doubly-charged b11
2+
 
to b15
2+
, b17
2+
, b19
2+
, triply-charged b20
3+
). Intense product ions corresponding to one or two H2O losses 
were observed for b17
2+
, b19
2+
 and b20
3+
. This behavior is most likely due to the presence of the T15 and 
S18 residues in the vicinity of the charge. The complementary y2, y4, y6, y7 and y8-H2O were also 
observed. Finally, only few internal product ions were detected, such as (b19y8)6-2H2O (m/z 567.3). As 
expected, two-peptide product ions were not detected. 
The IRMPD spectrum of the [M+3H]
3+
 species of MccJ25 (m/z 703.0) revealed to be less 
complex than the corresponding SORI-CID spectrum (Figure 3A, supplementary Table S3). The 
spectrum was dominated by the b series (b8 to b13, b16
2+
, b17
2+
 and b19
2+
 with one or two H2O losses). 
The y series consisted in y2, y3, y4, y6. Only few low abundance two-peptide product ions were detected: 
[(b16)*(y4)-H2O]
3+,2+
 (m/z 659.3, 988.5) and [(b15)*(y4)-H2O]
2+
 (m/z 939.9). This result contrasts with the 
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SORI-CID spectrum where these two peptide ions are produced in high abundance. In addition, several 
internal product ions were observed, in particular (b10y13)2 and/or (b20y3)2 (m/z 311.1), together with 
(b17y10)6-H2O (m/z 521.3). This fragmentation pattern illustrates that IRMPD triggers consecutive 
dissociation that result in multiple neutral losses and in the opening of the macrolactam ring, and 
therefore in the release of the entrapped C-terminal segment. A similar behavior towards IRMPD was 
observed for the [M+2H]
2+
 species of MccJ25 (data not shown). The IRMPD spectrum of the [M+3H]
3+
 
species of MccJ25-lcm showed a y/b fragmentation pattern close to that of MccJ25, but with a 
significantly higher fragmentation efficiency (Figure 3B, supplementary Table S4). While for the lasso 
peptide MccJ25 the precursor ion dominated the IRMPD spectrum, for the non-lasso topoisomer, the b13 
product ion was the most intense ion. The IRMPD spectra of MccJ25 and MccJ25-lcm were dominated 
by b/y series corresponding to cleavages within the C-terminal tail but were fairly different in terms of 
product ion relative abundance. The b17 to b20 product ions, corresponding to cleavages within the 
(SFYG) C-terminal segment, were favored for the lactame topoisomer as compared to the lasso. This 
can be explained by the burring of this segment in the macrolactame ring, which may strengthen the 
peptidic bonds in this region. Only the minor two-peptide product ions characteristic of the lasso 
topoisomer, i.e., [(b16)*(y4)-H2O]
3+,2+
 and [(b15)*(y4)-H2O]
2+
, could allow to unambiguously distinguish 
the two structures. 
SORI-CID is an “almost” resonant activation mode where only the precursor ion is effectively 
activated at its cyclotron frequency. With IRMPD, both the precursor ion and product ions present in the 
laser beam path are activated, which tend to enhance consecutive dissociation.
23
 Thus, the [(br)*(ys)] 
two-peptide product ions can dissociate, yielding the conventional ys or br product ions. Consecutive 
dissociation can also explain the high abundance of some internal product ions such as (b19y8)6-2H2O 
(m/z 567.3) (Figure 2B, 3B). In this regard, the SORI-CID spectrum presents more information about 
the existence of the lasso form, given the presence of the two-peptide product ions and although in this 
case the dissociation efficiency is lower as loss of water dominates the product ion spectrum. Thus, 
resonant activation mode that limits consecutive dissociation is more adequate for the structural 
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characterization of lasso peptides as it allows here to conserve intact two-peptide ions that are a direct 
proof of the threaded structure. 
The SORI-CID spectra of capistruin and capistruin-lcm (supplementary Figure S1) were poorly 
informative, as they showed mainly consecutive H2O and NH3 losses from the precursor ion. In 
addition, capistruin showed very weak y/b product ions resulting from cleavages in the C-terminal tail. 
The IRMPD spectra of capistruin and capistruin-lcm (Figure 4) also revealed mainly neutral losses, 
together with weak y/b series corresponding to cleavages in the C-terminal tail that were also affected 
by extensive neutral losses, and internal product ions. Many common product ions were detected for 
both topoisomers, but with different relative abundance and neutral loss patterns. As an example, the 
[b15-H2O]
2+
, [b16-H2O]
2+
, [b17-H2O]
2+
, [b18-H2O]
2+
 series dominated the m/z 700-1000 region in the 
IRMPD spectrum of capistruin, while this region was dominated by y6-NH3, y7-NH3, y8-NH3 for 
capistruin-lcm. This trend suggests that the product ions [b15-H2O]
2+
 to [b18-H2O]
2+
, more intense for the 
lasso topoisomer, correspond to lasso-structured product ions, maintained through R11 and R15 side-
chain located above and below the ring. Thus, as for MccJ25, the ergodic gas-phase fragmentations of 
capistruin appear to result in two dissociative processes, (i) the former preserving the lasso structure and 
yielding the [b15-H2O]
2+
 to [b18-H2O]
2+
 product ions, and (ii) the latter yielding y/b series corresponding 
to cleavages in the C-terminal tail, which indicates a previous precursor ion isomerization through 
opening of the macrolactam ring. However, the short sequence of the loop did not permit to generate 
two-peptide product ions, which require two bond cleavages in the loop region. Contrary to MccJ25 and 
its non-lasso topoisomer, the peptides capistruin and capistruin-lcm were not distinguished by CID, 
which was completely dominated by the water loss, but gave different product ion abundance profiles 
upon IRMPD, which suggests the formation of two-peptide product ions for the lasso topoisomer. This 
weak fragmentation behavior upon ergodic dissociative processes is attributed to the presence of R11 
and R15 residues in the tail region, which most probably sequester the protons. The lasso peptides 
MccJ25 and capistruin displayed a very extensive or very weak fragmentation extent, respectively, 
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which illustrates the influence basic amino acids on ergodic dissociation, in agreement with the mobile 
proton model.
31
 
Fragmentation patterns of MccJ25 and capistruin and their non-lasso topoisomers generated by ECD 
The ECD spectra of MccJ25 revealed different fragmentations patterns for the [M+2H]
2+
 and [M+3H]
3+
 
species (Figure 5 A,B). The doubly-charged species generated mainly a c series (c17, c18, c19, c20), 
together with two-peptide product ions: [(c9)*(y7)-H2O], [(c10)*(y7)-H2O] and [(c11)*(y7-H2O)]. Two 
relatively intense product ions at m/z 1298.7 and 1341.7 could not be assigned. The triply-charged 
species yielded a y series (y4, y6, y8) and b series (b10, b11, b13, b15) corresponding to + 1 u mass shifts, 
noted b’•n (Figure 5B). Almost no c/z
•
 ions were detected, with the exception of c18 (m/z 1738.8) and 
c19
2+
 (m/z 943.5). In addition, in a lower extent, two-peptide product ions such as [(b8)*(y12)]
2+
 and the 
series [(c8)*(y4)], [(c9)*(y4)] and [(c10)*(y4)] were present. Finally, c/y or b/y internal product ions 
corresponding to tail fragments, i.e., (c19y4)2, (c20y4)3, (c19y6)4, (c19y8)6, …, were detected. The non-lasso 
topoisomer MccJ25-lcm, dissociated upon ECD, showed certain trends common to its lasso topoisomer: 
a c11 to c20 series for the doubly-charged species (Figure 5C), and two competitive dissociation 
processes for the triply-charged species (Figure 5D): (i) ECD in the ring and consecutive y/ b’• series 
and (ii) ECD in the tail yielding a c/z
•
 series. As expected, the two-peptide product ions, characteristic 
of the lasso structure, were absent. Note that the dissociation efficiency of the charge-reduced species 
was significantly higher for the non-lasso peptide as compared to the lasso topoisomer. This illustrates 
the high stability of the lasso structure, as observed by CID. 
The almost complete absence of c/z
•
 ions for the [M+3H]
3+
 species of MccJ25 and MccJ25-lcm 
is quite unusual and should indicate a particular dissociation pathway. Indeed, electron capture is 
expected to yield charge-reduced species [M+3H]
•2+
 that consecutively undergo c/z
•
 cleavage. The b’• 
series and bipeptic product ions permitted to propose a competitive fragmentation pattern involving two 
isomeric charge-reduced species [M+3H]
•2+
 (m/z 1054.5) (Scheme 1). Most likely, the initial ECD 
occurred within the macrolactam ring, which is consistent with the presence of the basic histidine 
residue at position 5 (pathway a). The excess of energy in the [M+3H]
•2+
 charge-reduced species, due to 
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electron capture, would yield consecutive dissociation involving a conventional y/b cleavage within the 
C-terminal tail (b series corresponding to + 1 u mass shifts). On the other hand, an initial ECD in the C-
terminal tail (pathway b) would result in a two-peptide charge-reduced species [M+3H]
•2+
, further 
dissociated into two-peptide and internal product ions. Such pathways result from the presence of both a 
cyclic and a linear region in the peptide. Multiple backbone cleavages in cyclic peptides have been 
proposed to result from a free radical reaction cascade in which the -carbon radical formed by electron 
capture propagates along the peptide backbone by free radical rearrangements.
32
 For MccJ25 and 
MccJ25-lcm, which are both cyclic-branched peptides, the dissociation appear more complex, with both 
radical-driven and charge-driven bond cleavages. Such a competition between these two processes has 
been described recently for arginine-containing peptides, and the absence of basic residues is proposed 
to favor charge-driven fragmentations while arginine would promote radical-driven fragmentations.
33
 
The absence of basic residues in the tail of MccJ25 supports this tendency. 
For both CID and ECD, MccJ25 showed a fragmentation pattern typical of the lasso structure, 
which permits to assign the lasso character directly, even without a comparison to the non-lasso 
topoisomer. The formation of the typical two-peptide product ions is particularly favorable for MccJ25, 
as compared to capistruin given the large size of the loop above the ring and the vicinity of the two 
bulky amino acids that maintain the C-terminal tail entrapped within the ring. Many two-peptide 
product ions show y4 (SFYG) as minimal entrapped segment.  
The dissociation of the [M+3H]
3+
 and [M+2H]
2+
 species of capistruin and its topoisomer 
capistruin-lcm were also investigated under ECD conditions. The ECD spectra of the [M+2H]
2+
 species 
of capistruin and capistruin-lcm (supplementary Figure S2) revealed similar fragmentation patterns, 
with a c16 to c18 series. The ECD spectrum of the [M+3H]
3+
 species of capistruin (Figure 6A) showed an 
abundant charge-reduced species [M+3H]
•2+
, together with product ions resulting from neutral losses 
and a series of c and z
•
 ions. The product ion at m/z 996 corresponded to a loss of CH5N3 from the 
arginine side chain, a usual side chain cleavage in ECD.
34
 The z5
•
 to z9
•
 product ions corresponding to 
cleavages within the tail were fairly abundant. The complementary c11 to c18 were produced as singly-
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charged, but also as doubly-charged species for the larger product ions (c15 to c18). c11, the smallest c ion 
detected, corresponded to the cleavage after R11. The z10
•
 and z9
•
 product ions were detected, but in 
very low abundance. It should be noted that none of these main cleavages involves dissociation of the 
ring. This indicates that an initial cleavage produced after electron capture occurred within the tail. This 
is most likely due to the presence of the two basic residues (R11 and R15) in this region, which 
promotes local c/z
•
 fragmentations in ECD. However, some low abundance product ions were attributed 
to internal cleavages within the ring. The ECD spectrum of the [M+3H]
3+
 species of the capistruin-lcm 
topoisomer revealed a similar fragmentation pattern (Figure 6B), but with significant differences in the 
relative abundance of the product ions. In particular, the z10
•
 and z9
•
 product ions were detected in a 
much larger abundance as compared to capistruin. This trend suggests that when these cleavages occur 
for the lasso topoisomer capistruin, the two peptidic entities constitute two-peptide product ions as for 
MccJ25, due to the steric hindrance provided by R11 and R15 (as already suggested for CID 
experiments).
8
 In spite of this specific profile of product-ion abundances, no strong evidence of the lasso 
structure could be detected. 
Interestingly, part of the product ions corresponded to c and z
•
, but several c
•
 and z were also 
detected. Such a trend is relatively frequent during ECD dissociation of peptides and it has been 
proposed that the c
•
 and z species are produced from a hydrogen transfer occurring in a long life c/z
•
 
complex.
35-37
 For capistruin and capistruin-lcm topoisomers, the c
•
 ions revealed particularly abundant 
for cleavages of the tail nearby the ring. In addition, the relative abundance of c
•
/z species was strongly 
reduced for the non-lasso topoisomer. This behavior is illustrated in the spectra enlargement in Figure 
6C. In the non-lasso peptide, the normal c11 was mainly detected, while a significant amount of c11
•
 
species was detected for the lasso topoisomer. The same behavior was observed for z9, which was 
mostly detected as z9
•
 for the capistruin-lcm and as a mixture z9
•
/z9 for capistruin. Only a comparison 
with the non-lasso topoisomer permitted to assign the lasso structure of capistruin, with regard to the 
relative abundance of the product ions and the extent of hydrogen abstraction. Therefore, ECD appeared 
as more powerful in differentiating the two topoisomers capistruin and capistruin-lcm as compared to 
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ergodic dissociation and generated mainly c/z
•
 product ions within the C-terminal tail. The absence of 
y/b product ions suggested that electron capture occurred within the tail and yielded a free radical 
reaction cascade resulting in multiple backbone cleavages.  
 
CONCLUSIONS 
Our data showed that characterization of lasso peptides from gas-phase dissociation can be more or less 
complex depending on several parameters (Figure 1): (1) the size of the loop above the macrolactam 
ring, (2) the vicinity of the bulky amino acids in the C-terminal tail located above and below the 
macrolactame ring, (3) the presence of basic residues within the ring and the tail (that limits the 
fragmentation extent in ergodic dissociation and promote local fragmentations in ECD). ECD appears 
particularly promising, since it provides evidence of the lasso structure for both MccJ25 and capistruin. 
It generates competition between charge-driven and radical-driven bond cleavages, which orientation 
was strongly influenced by the presence or absence of arginines. The presence of two-peptide product 
ions is the main trend typical of the lasso structure and was clearly observed upon CID and ECD of 
MccJ25. For capistruin, the absence of double cleavage between D9 and R11 segment did not permit to 
detect it. 
The different hydrogen abstraction extent for the two topoisomers capistruin and capistruin-lcm 
is the first evidence of the influence of topology on this process, which was mainly interpreted with 
regard to the amino acid sequences. It suggests potential applications in the characterization of peptide 
or protein conformations, topology or non-covalent associations.  
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FIGURES AND TABLES 
Table 1 
Sequences and biological activities of type-II lasso peptides
a
 
Name Sequence 
Producing 
bacteria 
Biological activity Reference 
RES-701-1 ATGH P D WWNG WYYNFF
 
Streptomyces sp. 
RE-701 
Endothelin type B 
receptor selective 
antagonist 
9 
Anantinb NGWG DIFG I DGSY FHGF
 
Streptomyces 
coerulescens 
Atrial natriuretic 
factor antagonist 
12 
Propeptinb YDWW R D LPYG FTHGGF PSI
 
Microbispora 
sp. SNA-115 
Prolyl endopeptidase 
inhibitor 
11 
Lariatins 
RYVL EQSG W IVNS KHGV P PG
RYVL EQSG W IVNS KHGV P
 
Rhodococcus sp. 
K01-B0171 
Antimycobacterial 7 
Microcin 
J25 
PVHG EAGG Y PTGI IGVF S Y GF
 
Escherichia coli 
AY25 
Antibacterial 
RNA polymerase 
inhibitor 
10,15,17 
Capistruin TQFG P D APTG GFRS F NIVR
 
Bhurkholderia 
thailandensis 
E264 
Antibacterial 8 
a
 The sequences are represented unthreaded for clarity.
 
b
 The lasso structure (threading of the tail into the macrolactame ring) is hypothesized but has not been 
shown. 
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Figure 1. Three-dimensional structures of MccJ25
17
 (A) and capistruin
8
 (B). Scheme representing 
MccJ25 (C) and capistruin (D), showing the macrolactam ring in green, the C-terminal tail in blue and 
the bulky residues located above and below the macrolactame ring in magenta. 
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Figure 2. SORI-CID spectra of the [M+3H]
3+
 species of (A) MccJ25 and (B) MccJ25-lcm (m/z 703.0). 
Typical product ions are displayed on the right (the neutral losses are not indicated on the schemes for 
clarity). 
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Figure 3. IRMPD spectra of the [M+3H]
3+
 species of (A) MccJ25 and (B) MccJ25-lcm (m/z 703.0). The 
main product ions are displayed on the right (the neutral losses are not indicated on the schemes for 
clarity). 
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Figure 4. IRMPD spectra of the [M+3H]
3+
 species of (A) capistruin and (B) capistruin-lcm (m/z 683.7). 
The main product ions are displayed on the right (the neutral losses are not indicated on the schemes for 
clarity). 
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Figure 5. ECD spectra of (A) [M+2H]
2+
 of MccJ25 (m/z 1054.0) (B) [M+3H]
3+
 of MccJ25 (m/z 703.0), 
(C) [M+2H]
2+
 of MccJ25-lcm (m/z 1054.0) and (D) [M+3H]
3+
 of MccJ25-lcm (m/z 703.0). The main 
product ions are displayed (the neutral losses are not indicated on the schemes for clarity). 
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Figure 6. ECD spectra of the [M+3H]
3+
 species of (A) capistruin (B) and capistruin-lcm (m/z 683.7). 
Typical product ions are displayed. (C) c11/c11
•
 isotopic profiles obtained experimentally for capistruin 
and capistruin-lcm (on the left), and expected for c11 and c11
•
 (on the right). 
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Scheme 1. Pathways proposed for the ECD of the [M+3H]
3+
 species of MccJ25. 
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